What is Manifold Bio?
Manifold Bio is focused on engineering life-saving therapeutics by applying the power of multiplexed measurement. The company's mission is to innovate within the biotechnology and pharmaceutical sectors, leveraging advanced measurement techniques to accelerate the development of novel treatments. This strategic investment positions Manifold Bio for significant growth and further research and development.
How much funding has Manifold Bio raised?
Manifold Bio has raised a total of $45.4M across 2 funding rounds:
Angel/Seed
$5.4M
Series A
$40M
Angel/Seed (2020): $5.4M with participation from GETTYLAB, Fifty Years, Allston Venture Fund, and Playground Global
Series A (2022): $40M led by Playground Global, Section 32, Fifty Years, Horizons Ventures, Triatomic Capital, Tencent, and FPV Ventures
Key Investors in Manifold Bio
Fifty Years
Fifty Years is a venture capital firm focused on pre-seed and seed-stage companies that leverage technology to solve major global challenges, including disease. They support deep tech startups and help scientists transition into entrepreneurship.
Playground Global
Playground Global invests in founders using frontier technologies to build transformational businesses, with a focus on areas like life sciences. They provide expertise to help companies achieve their potential.
Tencent
Tencent is a global internet and technology company providing a wide range of services, including online games and applications. Their investment in Manifold Bio suggests an interest in the intersection of technology and life sciences.
What's next for Manifold Bio?
The recent major strategic investment signifies a pivotal moment for Manifold Bio, likely enabling the company to scale its operations, expand its research capabilities, and accelerate the clinical development of its therapeutic candidates. This capital infusion is expected to fuel innovation and solidify its market position in the competitive landscape of life-saving therapeutics.
See full Manifold Bio company page
